Scholarlink

Background <p>Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome is a&#xa0;rare inflammatory disease that manifests as a&#xa0;paraneoplastic manifestation of malignant tumors. Although its association with non-small cell lung cancer (NSCLC) is rare, vascular endothelial growth factor (VEGF)-A has been suggested to be involved in the pathogenesis. Cases with pleural and pericardial effusions are even rarer, and differentiation from metastasis of malignant tumors is important.</p> Case presentation <p>A&#xa0;51-year-old Asian man presented with fever, bilateral edema, tenosynovitis, pleural effusion, and pericardial effusion. Cytology of both effusions was negative for malignant cells, but mediastinal lymph node biopsy revealed adenocarcinoma. He was diagnosed with RS3PE syndrome associated with NSCLC. Oral prednisolone and chemoradiotherapy improved the edema and effusions. Serum VEGF‑A measured after clinical improvement was lower than that observed at recurrence. After curative resection of synchronous double primary lung cancers (adenocarcinoma and squamous cell carcinoma) and adjuvant chemotherapy, central nervous system metastases developed 10&#xa0;months later. This recurrence was accompanied by elevated serum and cerebrospinal fluid VEGF‑A levels and recurrence of RS3PE symptoms. Immunohistochemical analysis showed strong VEGF‑A expression in pretreatment tumor tissue, which decreased after treatment.</p> Discussion and conclusion <p>This case suggests that VEGF‑A may have contributed to paraneoplastic RS3PE syndrome in NSCLC. The association among the available VEGF‑A measurements, RS3PE activity, and cancer progression suggests that VEGF‑A may serve as a&#xa0;potential disease activity biomarker in selected patients. This case also highlights the importance of recognizing RS3PE syndrome as a&#xa0;paraneoplastic process and carefully evaluating pleuropericardial effusions and thrombotic complications in complex oncological patients.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Potentially VEGF-A-associated paraneoplastic RS3PE syndrome in non-small cell lung cancer with likely benign pleuropericardial effusions mimicking malignancy

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年8月4日

查看全文
  • Yuya Murase,
  • Hayato Koba,
  • Shigeki Nanjo,
  • Masato Hongo,
  • Yuki Seike,
  • Saya Tsukida,
  • Yoshihiro Yamamoto,
  • Ryo Hara,
  • Keigo Saeki,
  • Taro Yoneda,
  • Sachiko Arai,
  • Yuichi Tambo,
  • Kenta Yamamura,
  • Satoshi Watanabe,
  • Noriyuki Ohkura,
  • Miki Abo,
  • Shigeyuki Takamatsu,
  • Isao Matsumoto,
  • Seiji Yano

摘要

Background

Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome is a rare inflammatory disease that manifests as a paraneoplastic manifestation of malignant tumors. Although its association with non-small cell lung cancer (NSCLC) is rare, vascular endothelial growth factor (VEGF)-A has been suggested to be involved in the pathogenesis. Cases with pleural and pericardial effusions are even rarer, and differentiation from metastasis of malignant tumors is important.

Case presentation

A 51-year-old Asian man presented with fever, bilateral edema, tenosynovitis, pleural effusion, and pericardial effusion. Cytology of both effusions was negative for malignant cells, but mediastinal lymph node biopsy revealed adenocarcinoma. He was diagnosed with RS3PE syndrome associated with NSCLC. Oral prednisolone and chemoradiotherapy improved the edema and effusions. Serum VEGF‑A measured after clinical improvement was lower than that observed at recurrence. After curative resection of synchronous double primary lung cancers (adenocarcinoma and squamous cell carcinoma) and adjuvant chemotherapy, central nervous system metastases developed 10 months later. This recurrence was accompanied by elevated serum and cerebrospinal fluid VEGF‑A levels and recurrence of RS3PE symptoms. Immunohistochemical analysis showed strong VEGF‑A expression in pretreatment tumor tissue, which decreased after treatment.

Discussion and conclusion

This case suggests that VEGF‑A may have contributed to paraneoplastic RS3PE syndrome in NSCLC. The association among the available VEGF‑A measurements, RS3PE activity, and cancer progression suggests that VEGF‑A may serve as a potential disease activity biomarker in selected patients. This case also highlights the importance of recognizing RS3PE syndrome as a paraneoplastic process and carefully evaluating pleuropericardial effusions and thrombotic complications in complex oncological patients.